Related Experiment Videos
Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients
M A Jenike1, L Baer, P Summergrad
1Harvard Medical School and Massachusetts General Hospital, Boston 02114.
The American Journal of Psychiatry
|October 1, 1989
Abstract:
Clomipramine was significantly superior to placebo in a 10-week double-blind, placebo-controlled trial in 27 outpatients who met DSM-III-R criteria for obsessive-compulsive disorder.